Literature DB >> 19337235

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Darwin J Prockop1.   

Abstract

Research on stem cells has progressed at a rapid pace and, as might be anticipated, the results have generated several controversies, a few myths and a change in a major paradigm. Some of these issues will be reviewed in this study with special emphasis on how they can be applied to the adult stem/progenitor cells from bone marrow, referred to as MSCs.

Mesh：

Year:  2009        PMID： 19337235      PMCID： PMC2835176          DOI： 10.1038/mt.2009.62

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


  93 in total

Review 1.  Mesenchymal stem cells: progress toward promise.

Authors:  K Le Blanc; Mf Pittenger
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

Review 2.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment.

Authors:  Yoshitaka Iso; Jeffrey L Spees; Claudia Serrano; Benjamin Bakondi; Radhika Pochampally; Yao-Hua Song; Burton E Sobel; Patrick Delafontaine; Darwin J Prockop
Journal:  Biochem Biophys Res Commun       Date:  2007-01-17       Impact factor: 3.575

Review 4.  Immune plasticity of bone marrow-derived mesenchymal stromal cells.

Authors:  J Stagg; J Galipeau
Journal:  Handb Exp Pharmacol       Date:  2007

5.  Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

Authors:  R Ramasamy; E W-F Lam; I Soeiro; V Tisato; D Bonnet; F Dazzi
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

6.  Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

Authors:  Florian Tögel; Kathleen Weiss; Ying Yang; Zhuma Hu; Ping Zhang; Christof Westenfelder
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-09

7.  Sarcoma derived from cultured mesenchymal stem cells.

Authors:  Jakub Tolar; Alma J Nauta; Mark J Osborn; Angela Panoskaltsis Mortari; Ron T McElmurry; Scott Bell; Lily Xia; Ning Zhou; Megan Riddle; Tania M Schroeder; Jennifer J Westendorf; R Scott McIvor; Pancras C W Hogendoorn; Karoly Szuhai; Leann Oseth; Betsy Hirsch; Stephen R Yant; Mark A Kay; Alexandra Peister; Darwin J Prockop; Willem E Fibbe; Bruce R Blazar
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

8.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.

Authors:  Luis A Ortiz; Maria Dutreil; Cheryl Fattman; Amitabh C Pandey; German Torres; Kristina Go; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-14       Impact factor: 11.205

9.  Stem cell transplantation: the lung barrier.

Authors:  S Schrepfer; T Deuse; H Reichenspurner; M P Fischbein; R C Robbins; M P Pelletier
Journal:  Transplant Proc       Date:  2007-03       Impact factor: 1.066

Review 10.  Male and female Drosophila germline stem cells: two versions of immortality.

Authors:  Margaret T Fuller; Allan C Spradling
Journal:  Science       Date:  2007-04-20       Impact factor: 47.728
View more
  215 in total

1.  Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes.

Authors:  Carmen Mariana Aanei; Pascale Flandrin; Florin Zugun Eloae; Eugen Carasevici; Denis Guyotat; Eric Wattel; Lydia Campos
Journal:  Stem Cells Dev       Date:  2011-10-27       Impact factor: 3.272

2.  Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Authors:  Benjamin L Larson; Joni Ylostalo; Ryang H Lee; Carl Gregory; Darwin J Prockop
Journal:  Tissue Eng Part A       Date:  2010-07-13       Impact factor: 3.845

Review 3.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

4.  Chondrogenic progenitor cells respond to cartilage injury.

Authors:  Dongrim Seol; Daniel J McCabe; Hyeonghun Choe; Hongjun Zheng; Yin Yu; Keewoong Jang; Morgan W Walter; Abigail D Lehman; Lei Ding; Joseph A Buckwalter; James A Martin
Journal:  Arthritis Rheum       Date:  2012-11

5.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.

Authors:  Thomas J Bartosh; Joni H Ylöstalo; Arezoo Mohammadipoor; Nikolay Bazhanov; Katie Coble; Kent Claypool; Ryang Hwa Lee; Hosoon Choi; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

6.  Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia.

Authors:  S Keisin Wang; Linden A Green; Natalie A Drucker; Raghu L Motaganahalli; Andres Fajardo; Michael P Murphy
Journal:  J Vasc Surg       Date:  2018-02-01       Impact factor: 4.268

7.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

8.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

Review 9.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 10.  Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.

Authors:  Jakub Tolar; John E Wagner
Journal:  Lancet       Date:  2013-10-05       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.